Schulze, Friedrich

Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism

Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F., & Böger, R. H. (2008) · British Journal of Clinical Pharmacology

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 494

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation

Nitric Oxide and Endothelin EffectsCancer-related gene regulation

Cited by 351

Association of Plasma ADMA Levels With MRI Markers of Vascular Brain Injury: Framingham Offspring Study

Pikula, A., Böger, R. H., Beiser, A. S., Maas, R., DeCarli, C., Schwedhelm, E., Himali, J. J., Schulze, F., Au, R., Kelly-Hayes, M., et al. (2009) · Stroke

Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research

Cited by 85

Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality

Böger, R. H., Maas, R., Schulze, F., & Schwedhelm, E. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM)

Nitric Oxide and Endothelin EffectsCancer-related gene regulation

Cited by 65